- Treatment of non-muscle invasive bladder cancer with Bacillus Calmette–Guerin (BCG): Biological markers and simulation studies
Alex Kiselyov et al, 2015, BBA Clinical CrossRef - Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma
Tibor Szarvas et al, 2018, Urothelial Carcinoma CrossRef - Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis
Xinliang Ming et al, 2019, Technology in Cancer Research & Treatment CrossRef - Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats
Nao Yukimatsu et al, 2019, Archives of Toxicology CrossRef - Association between interleukin-22 genetic polymorphisms and bladder cancer risk
Tao Zhao et al, 2015, Clinics CrossRef - Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization
Andrew J. Sawyer et al, 2016, Advanced Drug Delivery Reviews CrossRef - A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer
Jamie J. D’Costa et al, 2016, Bladder Cancer CrossRef - The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer
YiHeng Du et al, 2021, Cancer Cell International CrossRef - The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment
Casimiro Gerarduzzi et al, 2020, Cancer Research CrossRef - Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation
Zhenfeng Guan et al, 2022, BMC Cancer CrossRef